Massive Bio, a provider of AI-driven oncology solutions, has partnered with Un Ensayo Para Mi (UEPM), a prominent Latin American clinical trial search platform.
The partnership aims to expand access to crucial clinical trials to nine countries in the Latin America region, including Mexico, Colombia, Brazil, and Argentina.
The alliance between Massive Bio and UEPM will utilize the network of UEPM and Massive Bio's AI technology to create a more accessible and efficient clinical trial enrollment process for cancer patients in Latin America. The partnership is expected to align innovative treatments with the patients most in need. Integrating Massive Bio's AI solutions into UEPM's platform also promises to speed up and improve the accuracy of matching patients with suitable clinical trials, which could increase participation rates and advance cancer research in the region.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.